Maxar Statement on COVID-19
Summary
In our Space Infrastructure business, no supply chain interruptions have occurred to date, and Maxar remains in close coordination with customers on potential risks and mitigations. The acquisition of MDA by a consortium led by Northern Private Capital continues to progress through the regulatory approval process, with close of the transaction expected in the spring or early summer as previously indicated. The closing is not subject to any financing contingency, and the definitive agreement defines material adverse effect in a customary way that excludes both general economic, financial and capital market conditions, and acts of God and other force majeure events. Our unique approach combines decades of deep mission understanding and a proven commercial and defense foundation to deploy solutions and deliver insights with unrivaled speed, scale and cost effectiveness. The Company disclaims any intention or obligation to update or revise any forward-looking statements in this presentation as a result of new information or future events, except as may be required under applicable securities legislation.